3557 results for «303»
3557 results
Hotlines and innovations on stable CAD - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of stable CAD:
- ANGIE trial
- Prevention of AKI with sodium bicarbonate
- AI-based plaque characterisation

Hotlines and innovations on bifurcation lesions - PCR e-Course 2020
View this hot line from PCR e-Course 2020 on the topic of bifurcation stenting regarding the role of deployment technique in a global registry.

Hotlines and innovations on other coronary interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:
- Gender differences in outcomes after rational atherectomy PCI
- Intensified antiplatelet therapy in post-PCI patients with HOPR

Hotlines and innovations on STEMI - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of STEMI:
- Stenosis Severity and Complete Revascularisation in STEMI
- Analysis of changes in decision-making process during OCT-guided PCI

TAVI and the conduction system
27 Jun 2020 – From PCR e-Course 2020
Watch this case discussion if you want to appreciate the factors that predict conduction abnormalities during TAVI (and how to avoid them), to understand which patients are at risk of late abnormalities and need prolonged monitoring after TAVI and to identify which patients require permanent pacemaker...

My Toolbox for iliac and femoral interventions with Benjamin Honton
22 May 2019 – From EuroPCR 2019
Consult this session to discover Benjamin Honton's toolbox for iliac and femoral interventions, depending on the disease's level. Learn more about the tools you need to enhance your clinical practice!

Update on management of complex calcified coronary lesions
23 May 2019 – From EuroPCR 2019
Consult this session to discover updates on the management of complex calcified coronary lesions, to better understand which cases may be almost impossible to stent, to learn techniques to make stenting possible, and more!

Coronary drug-coated balloons - Why, when and how
23 May 2019 – From EuroPCR 2019
Consult this session to discover practical tips about coronary drug-coated balloon, and learn more about its use, where it may provide a clinical benefit, and more!

Emerging transcatheter-based interventions for volume management in advanced heart failure
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about emerging device-based approach in heart failure with preserved ejection fraction, the devices specifics and how to use them, and more!

Reducing long term ischaemic events in high-risk patients: the role of intensified antithrombotic treatment
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of intensified antithrombotic treatment in improving cardiovascular outcomes in high-risk patients and how to implement this treatment.

What's new in hypertension treatment – An update for interventionists
23 May 2019 – From EuroPCR 2019
Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!

Ability to treat diabetic patients: DES + DCB strategy
23 May 2019 – From EuroPCR 2019
Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Complex aortoiliac bifurcation treatment - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.
LIVE demonstration from Clinique Pasteur - Toulouse, France

RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system in a randomised, blinded, sham-controlled study
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest results from the RADIANCE-HTN SOLO cohort at the 6-month time point to assess efficacy of renal denervation in patients after medication titration.

Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond
23 May 2019 – From EuroPCR 2019
Consult this session on innovations in complex multivessel disease PCI to learn more about the recent innovations in physiology and IVUS guidance and to review current data on rotational atherectomy for calcified lesion preparation.

Precision meets simplicity – Complex PCI guided by a 2nd generation fibre optic physiology guidewire
23 May 2019 – From EuroPCR 2019
Consult this session to learn through various compelling clinical cases how the new OptoWire physiology guidewire can make the difference compared to the current pressurewires, and how to use it in bifurcations, serial lesions and CAD and aortic stenoses.

Latest developments in cerebral embolic protection
23 May 2019 – From EuroPCR 2019
Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.

New trials in coronary imaging and physiology
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!

Complex PCI in high bleeding risk patients
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.

PCI complications in daily practice: patient, device or doctor?
23 May 2019 – From EuroPCR 2019
Consult this session on PCI complications in daily practice and learn through compelling cases all about the successful and unsuccessful steps taken to solve adverse events.
